Keywords: AstraZeneca, CrystalGenomics, Anti-infectives, AC Immune, Alzheimer's Moscow University, Licensing, Morphomer

AstraZeneca gets novel anti-infective for Korean firm, AC Immune adds to Alzheimer’s portfolio with Russian drug

Article | 14 January 2010

Anglo-Swedish drug major AstraZeneca has entered into a research collaboration with South Korea-based CrystalGenomics to discover and develop a novel ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in